NDC 61703-155-01
Cytarabine 100 mg/mL
CYTARABINE · INJECTION, SOLUTION
Cytarabine is a chemotherapy medication injected directly into the fluid surrounding the spinal cord to treat certain cancers, particularly leukemia and lymphoma that affect the central nervous system. It works by interfering with cancer cell growth and division.
Key Facts
- Brand Name
- Cytarabine
- Generic Name
- CYTARABINE
- NDC Code (Package)
61703-155-01- NDC Code (Product)
61703-155- Manufacturer
- Hospira, Inc.
- Strength
- 100 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRATHECAL, INTRAVENOUS, SUBCUTANEOUS
- Marketing Status
- Application #
- ANDA075383
- Drug Class
- Nucleoside Metabolic Inhibitor [EPC]
- Marketing Start
- 04/07/2025
Recall History
No Recall HistoryView Full Drug Page
Cytarabine — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.